Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity

Jie Zhang; Valina L. Dawson; Ted M. Dawson; Solomon H. Snyder

doi:10.1016/S0734-9750(97)88683-1

Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity

School of Medicine

Research output: Contribution to journal › Article › peer-review

Abstract

Inhibitors of poly(ADP-ribose) synthetase can be used to prevent neurotoxicity mediated through N-methyl-D-aspartate (NMDA) receptors. Poly(ADP-ribose) synthetase inhibitors can be used therapeutically in the treatment of vascular stroke and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and Huntington's disease.

Original language	English (US)
Pages (from-to)	771
Number of pages	1
Journal	Biotechnology Advances
Volume	15
Issue number	3-4
DOIs	https://doi.org/10.1016/S0734-9750(97)88683-1
State	Published - 1997

ASJC Scopus subject areas

Biotechnology
Bioengineering
Applied Microbiology and Biotechnology

Access to Document

10.1016/S0734-9750(97)88683-1

Cite this

@article{4ce0ce1f151f493186c9a1581b74f9d3,

title = "Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity",

abstract = "Inhibitors of poly(ADP-ribose) synthetase can be used to prevent neurotoxicity mediated through N-methyl-D-aspartate (NMDA) receptors. Poly(ADP-ribose) synthetase inhibitors can be used therapeutically in the treatment of vascular stroke and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and Huntington's disease.",

author = "Jie Zhang and Dawson, \{Valina L.\} and Dawson, \{Ted M.\} and Snyder, \{Solomon H.\}",

year = "1997",

doi = "10.1016/S0734-9750(97)88683-1",

language = "English (US)",

volume = "15",

pages = "771",

journal = "Biotechnology Advances",

issn = "0734-9750",

publisher = "Elsevier Inc.",

number = "3-4",

}

TY - JOUR

T1 - Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity

AU - Zhang, Jie

AU - Dawson, Valina L.

AU - Dawson, Ted M.

AU - Snyder, Solomon H.

PY - 1997

Y1 - 1997

N2 - Inhibitors of poly(ADP-ribose) synthetase can be used to prevent neurotoxicity mediated through N-methyl-D-aspartate (NMDA) receptors. Poly(ADP-ribose) synthetase inhibitors can be used therapeutically in the treatment of vascular stroke and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and Huntington's disease.

AB - Inhibitors of poly(ADP-ribose) synthetase can be used to prevent neurotoxicity mediated through N-methyl-D-aspartate (NMDA) receptors. Poly(ADP-ribose) synthetase inhibitors can be used therapeutically in the treatment of vascular stroke and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and Huntington's disease.

UR - https://www.scopus.com/pages/publications/0030678980

UR - https://www.scopus.com/pages/publications/0030678980#tab=citedBy

U2 - 10.1016/S0734-9750(97)88683-1

DO - 10.1016/S0734-9750(97)88683-1

M3 - Article

AN - SCOPUS:0030678980

SN - 0734-9750

VL - 15

SP - 771

JO - Biotechnology Advances

JF - Biotechnology Advances

IS - 3-4

ER -

Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this